Sirolimus conversion for renal preservation in liver transplantation: not so fast

Liver Transpl. 2008 May;14(5):601-3. doi: 10.1002/lt.21452.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antimetabolites / therapeutic use
  • Calcineurin Inhibitors*
  • Creatinine / blood
  • Cyclosporine / administration & dosage
  • Cyclosporine / adverse effects*
  • Disease Progression
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Graft Rejection / etiology
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects*
  • Liver Diseases / complications
  • Liver Diseases / drug therapy*
  • Liver Diseases / metabolism
  • Liver Diseases / mortality
  • Liver Diseases / surgery
  • Liver Transplantation* / adverse effects
  • Renal Insufficiency, Chronic / chemically induced*
  • Renal Insufficiency, Chronic / metabolism
  • Renal Insufficiency, Chronic / mortality
  • Renal Insufficiency, Chronic / therapy
  • Renal Replacement Therapy
  • Sirolimus / administration & dosage
  • Sirolimus / adverse effects*
  • Tacrolimus / administration & dosage
  • Tacrolimus / adverse effects*
  • Treatment Outcome

Substances

  • Antimetabolites
  • Calcineurin Inhibitors
  • Immunosuppressive Agents
  • Cyclosporine
  • Creatinine
  • Sirolimus
  • Tacrolimus